SCHEMBL2590909

SCHEMBL2590909

Cc1c(P(=S)(c2ccccc2)c2ccccc2)c2ccccc2n1C(=O)NCc1ccccc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 8/20 1.00
ASAH1 Q13510 4/20 0.45
KDM4E B2RXH2 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
EGFR P00533 1/20 0.42
SRC P12931 1/20 0.42
MEN1 O00255 1/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
KMT2A Q03164 1/20 0.41
LMNA P02545 1/20 0.40
ALDH1A1 P00352 1/20 0.40
POLB P06746 1/20 0.40
PKM P14618 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2587913 0.92 NPSR1 (1.00) NPSR1ASAH1SMN1; SMN2MEN1RAB9A
SCHEMBL2593079 0.78 NPSR1 (1.00) NPSR1ASAH1SMN1; SMN2MEN1NPC1
SCHEMBL2586617 0.72 NPSR1 (1.00) NPSR1ASAH1KDM4ESMN1; SMN2LMNA
SCHEMBL2593998 0.72 NPSR1 (0.63) NPSR1MEN1KMT2AALDH1A1POLB
SCHEMBL2587268 0.72 NPSR1 (0.63) NPSR1KDM4ESMN1; SMN2MEN1KMT2A
SCHEMBL2595693 0.71 NPSR1 (1.00) NPSR1KDM4EMEN1NPC1RAB9A
SCHEMBL2586615 0.70 NPSR1 (0.54) NPSR1KDM4EALDH1A1
SCHEMBL2586743 0.69 NPSR1 (0.58) NPSR1KDM4ESMN1; SMN2ALDH1A1
SCHEMBL28756722 0.68 GAA (0.52) NPSR1KDM4ESMN1; SMN2MEN1KMT2A
SCHEMBL2590676 0.66 NPSR1 (1.00) NPSR1ASAH1SMN1; SMN2MEN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011137220-A1 SMALL MOLECULE NEUROPEPTIDE S ANTAGONISTS FOR THE TREATMENT OF ADDICTIVE DISORDERS, MOOD, ANXIETY AND SLEEP DISORDERS THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2011-11-03 WO disclosed
WO-2011137220-A1 SMALL MOLECULE NEUROPEPTIDE S ANTAGONISTS FOR THE TREATMENT OF ADDICTIVE DISORDERS, MOOD, ANXIETY AND SLEEP DISORDERS THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2011-11-03 WO disclosed